Establishing the Role of PPARβ/δ in Carcinogenesis

Trends Endocrinol Metab. 2015 Nov;26(11):595-607. doi: 10.1016/j.tem.2015.09.004. Epub 2015 Oct 18.

Abstract

The role of the nuclear hormone receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in carcinogenesis is controversial because conflicting studies indicate that it both inhibits and promotes tumorigenesis. In this review, we focus on recent studies on PPARβ/δ including the significance of increased or decreased PPARβ/δ expression in cancers; a range of opposing mechanisms describing how PPARβ/δ agonists, antagonists, and inverse agonists regulate tumorigenesis and/or whether there may be cell context-specific mechanisms; and whether activating or inhibiting PPARβ/δ is feasible for cancer chemoprevention and/or therapy. Research questions that need to be addressed are highlighted to establish whether PPARβ/δ can be effectively targeted for cancer chemoprevention.

Keywords: cancer; chemoprevention; mechanisms; peroxisome proliferator-activated receptor-β/δ; transcription factor.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Carcinogenesis / drug effects
  • Carcinogenesis / metabolism*
  • Humans
  • PPAR delta / agonists
  • PPAR delta / antagonists & inhibitors
  • PPAR delta / metabolism*
  • PPAR-beta / agonists
  • PPAR-beta / antagonists & inhibitors
  • PPAR-beta / metabolism*

Substances

  • PPAR delta
  • PPAR-beta